These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Comparison of in vivo and in vitro properties of cyclic adenosine 3':5'-monophosphate phosphodiesterase of amphibian oocytes. Allende CC; Bravo R; Allende JE J Biol Chem; 1977 Jul; 252(13):4662-6. PubMed ID: 194890 [No Abstract] [Full Text] [Related]
50. Inhibitory and activators of cyclic nucleotide phosphodiesterase. Chasin M; Harris DN Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316 [No Abstract] [Full Text] [Related]
51. [Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase]. Sobolev AS; Orekhov AN; Dhirkov IuIu; Kudriashov IuB Dokl Akad Nauk SSSR; 1975 Sep; 224(3):713-6. PubMed ID: 173507 [No Abstract] [Full Text] [Related]
52. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones. Goff AK; Major PW FEBS Lett; 1976 Jan; 61(2):144-7. PubMed ID: 174943 [No Abstract] [Full Text] [Related]
53. Mediation of serum-induced changes in cyclic nucleotide levels in cultured fibroblasts by cyclic nucleotide phosphodiesterase. Pledger WJ; Thompson WJ; Strada SJ Nature; 1975 Aug; 256(5520):729-31. PubMed ID: 168501 [No Abstract] [Full Text] [Related]
54. Multiple cyclic nucleotide phosphodiesterases in rat kidney. Gulyassy PF; Farrand JR; Gugler HD Kidney Int; 1975 Nov; 8(5):284-91. PubMed ID: 537 [TBL] [Abstract][Full Text] [Related]
55. Cylic nucleotide phosphodiesterase in silkworm. Characterization of cyclic GMP phosphodiesterase. Morishima I Biochim Biophys Acta; 1975 Dec; 410(2):310-7. PubMed ID: 1092 [TBL] [Abstract][Full Text] [Related]
56. Cyclic nucleotide phosphodiesterase in silkworm. Developmental change of cyclic AMP and cyclic GMP phosphodiesterases. Morishima I Biochim Biophys Acta; 1975 Sep; 403(1):106-12. PubMed ID: 240422 [TBL] [Abstract][Full Text] [Related]
57. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Eckly AE; Lugnier C Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194 [TBL] [Abstract][Full Text] [Related]
58. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung. Fertel R; Weiss B Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099 [No Abstract] [Full Text] [Related]
59. Studies on cyclic adenosine 3' ,5'-monophosphate levels, Adenylate cyclase and phosphodiesterase activities in the dimorphic fungus Mucor rouxii. Paveto C; Epstein A; Passeron S Arch Biochem Biophys; 1975 Aug; 169(2):449-57. PubMed ID: 170864 [No Abstract] [Full Text] [Related]
60. Interaction of plasma membranes with influenza virus. VII. Effect on 3',5'-cyclic adenosine monophosphate phosphodiesterase activity. Krizanová O; Lacinová D; Knopp J Acta Virol; 1977 Mar; 21(2):97-103. PubMed ID: 17292 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]